من مخترع مضاد الكليندامايسين الحيوي ؟
Clindamycin is a semisynthetic derivative of lincomycin, a natural antibiotic produced by the actinobacterium "Streptomyces lincolnensis". It is obtained by 7("S")-chloro-substitution of the 7("R")-hydroxyl group of lincomycin. The synthesis of clindamycin was first announced by BJ Magerlein, RD Birkenmeyer, and F Kagan on the fifth Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in 1966. It has been on the market since 1968.
BJ Magerlein, RD Birkenmeyer, and F Kagan